Nexavar 200 mg Tablet – Sorafenib for Liver, Kidney and Thyroid Cancer
Nexavar 200 mg Tablet contains Sorafenib 200 mg, a prescription targeted anticancer medicine used to treat patients with advanced renal cell carcinoma (RCC), a type of kidney cancer. Sorafenib is widely used in the treatment of liver cancer, kidney cancer, and thyroid cancer, including unresectable liver cancer and progressive differentiated thyroid cancer that no longer responds to radioactive iodine treatment. Oncologists may also prescribe sorafenib for advanced and refractory desmoid tumors that keep growing despite earlier treatment. Sorafenib belongs to a class of medicines known as multikinase inhibitors. It blocks certain proteins involved in the growth and multiplication of cancer cells. It also reduces the development of new blood vessels that supply the tumour, helping slow the progression of the disease. Nexavar 200 mg Tablet must be used only under the supervision of an oncologist experienced in anticancer treatment. The dosage, duration, treatment interruptions, and dose reductions depend on the patient’s condition, treatment response, and side effects.
Key Features
- Contains Sorafenib 200 mg: A targeted multikinase inhibitor.
- Used for Liver, Kidney and Thyroid Cancer: Indicated for the treatment of liver cancer, kidney cancer, and thyroid cancer.
- Targeted Anticancer Therapy: Blocks proteins involved in tumour-cell growth and blood-vessel formation.
- Oral Treatment: Supplied as a film-coated tablet for oral administration.
- Requires Regular Monitoring: Blood pressure, liver function, skin reactions, and treatment response should be monitored.
Active Ingredient
- Sorafenib 200 mg
Uses
- Treatment of advanced renal cell carcinoma, also known as advanced kidney cancer.
- Treatment of unresectable hepatocellular carcinoma (liver cancer).
- Treatment of progressive differentiated thyroid cancer not responding to radioactive iodine.
- Sorafenib for advanced and refractory desmoid tumors, as advised by an oncologist.
How to Use
- Take Nexavar exactly as prescribed by your oncologist.
- Swallow the tablets whole with water.
- Do not crush, chew, split, or dissolve the tablets.
- Take each dose at approximately the same time every day.
- Do not change the dosage or stop treatment without consulting your oncologist.
Precautions
- Use only under the supervision of a qualified oncologist.
- Liver-function tests and other laboratory investigations may be required during treatment.
- Inform your healthcare provider before undergoing surgery, as sorafenib may affect wound healing.
- Inform your doctor if you take warfarin, rifampicin, neomycin, seizure medicines, or medicines that may affect heart rhythm.
- Breastfeeding is not recommended during treatment and for the period advised after the final dose.
Storage
- Store at controlled room temperature between 20°C and 25°C.
- Store in a dry place and protect the tablets from moisture.
- Keep the tablets in their original packaging until use.
- Do not use the medicine after the expiry date printed on the packaging.
- Keep out of reach of children and pets.
FAQs
1. Nexavar 200 mg Tablet is prescribed for adults with advanced liver cancer, kidney cancer, or differentiated thyroid cancer. It should only be used under the supervision of an oncologist.
2. In some cases, Nexavar may be used alongside other cancer treatments, but only if your doctor recommends it. Do not combine it with any medication without medical advice.
3. Hair thinning or mild hair loss can occur during treatment. This side effect is usually manageable, but inform your doctor if it becomes severe.
4. Stay hydrated, eat a balanced diet, monitor your blood pressure, avoid smoking and excessive alcohol, and attend all scheduled follow-up appointments to help manage your treatment safely.
5. Nexavar may be used for an extended period as long as it remains effective and the side effects are manageable. Your doctor will decide how long your treatment should continue.
Legal Disclaimer: Nexavar 200 mg Tablet is a prescription anticancer medicine intended for use only under the supervision of a qualified oncologist. It can cause serious or life-threatening adverse effects and requires appropriate medical monitoring. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the official prescribing information supplied with the medicine.
Reviews
There are no reviews yet.